- Home
- TRS vs NVCR Comparison
TRS vs NVCR Comparison
Compare TRS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- NVCR
- Stock Information
- Founded
- TRS 1986
- NVCR 2000
- Country
- TRS United States
- NVCR Switzerland
- Employees
- TRS N/A
- NVCR N/A
- Industry
- TRS Industrial Specialties
- NVCR Medical/Dental Instruments
- Sector
- TRS Industrials
- NVCR Health Care
- Exchange
- TRS Nasdaq
- NVCR Nasdaq
- Market Cap
- TRS 1.5B
- NVCR 1.4B
- IPO Year
- TRS 2007
- NVCR 2015
- Fundamental
- Price
- TRS $37.02
- NVCR $13.48
- Analyst Decision
- TRS Strong Buy
- NVCR Buy
- Analyst Count
- TRS 2
- NVCR 7
- Target Price
- TRS $45.00
- NVCR $28.07
- AVG Volume (30 Days)
- TRS 359.9K
- NVCR 1.2M
- Earning Date
- TRS 10-28-2025
- NVCR 10-30-2025
- Dividend Yield
- TRS 0.43%
- NVCR N/A
- EPS Growth
- TRS 68.70
- NVCR N/A
- EPS
- TRS 1.08
- NVCR N/A
- Revenue
- TRS $1,013,740,000.00
- NVCR $630,160,000.00
- Revenue This Year
- TRS $11.03
- NVCR $6.68
- Revenue Next Year
- TRS $6.91
- NVCR $7.01
- P/E Ratio
- TRS $34.27
- NVCR N/A
- Revenue Growth
- TRS 11.83
- NVCR 14.58
- 52 Week Low
- TRS $19.33
- NVCR $10.87
- 52 Week High
- TRS $40.34
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- TRS 44.57
- NVCR 48.17
- Support Level
- TRS $35.10
- NVCR $13.53
- Resistance Level
- TRS $40.30
- NVCR $14.17
- Average True Range (ATR)
- TRS 1.30
- NVCR 0.60
- MACD
- TRS 0.06
- NVCR -0.10
- Stochastic Oscillator
- TRS 36.92
- NVCR 36.36
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.